Page last updated: 2024-10-28

hydralazine and Stevens-Johnson Syndrome

hydralazine has been researched along with Stevens-Johnson Syndrome in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.

Research Excerpts

ExcerptRelevanceReference
"Hydralazine is an effective antihypertensive drug which acts by vasodilatation."1.40Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis. ( Chan, JC; Yap, DY; Yeung, CK, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, JC1
Yap, DY1
Yeung, CK1

Other Studies

1 other study available for hydralazine and Stevens-Johnson Syndrome

ArticleYear
Hydralazine-induced toxic epidermal necrolysis in a patient on continuous ambulatory peritoneal dialysis.
    Journal of clinical pharmacy and therapeutics, 2014, Volume: 39, Issue:3

    Topics: Aged; Female; Humans; Hydralazine; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulato

2014